One of the main messages of the Global Summit on Regulatory Science (GSRS17) held in Brasilia in September was that decision-making about safety assessment is undergoing a major transition.
Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.